Related Experiment Videos

Activation of human squamous cell carcinoma ornithine decarboxylase activity by guanosine triphosphate

O Hietala1, L Dzubow, A A Dlugosz

  • 1Wistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania 19104.

Cancer Research
|March 1, 1988
PubMed

Insights

Human skin cancer cells show altered ornithine decarboxylase (ODC) enzyme activity. This key enzyme may be aberrantly regulated in squamous cell carcinomas, offering potential new therapeutic targets.

Area of Science:

  • Biochemistry
  • Oncology
  • Dermatology

Background:

  • Previous studies identified altered ornithine decarboxylase (ODC) in mouse skin tumors.
  • ODC is a critical enzyme in polyamine synthesis, linked to cell growth and proliferation.

Purpose of the Study:

  • To investigate the enzymatic properties of ODC in normal human skin and human squamous cell carcinomas.
  • To determine if ODC in tumors exhibits altered heat stability, GTP responsiveness, and molecular forms compared to normal skin ODC.

Main Methods:

  • Enzyme assays were performed on ODC extracted from normal human skin and squamous cell carcinoma tissues.
  • GTP stimulation assays, kinetic analyses (Km, Vmax), gel filtration chromatography, and immunolocalization were utilized.

Main Results:

  • Some tumor ODC exhibited increased heat stability compared to normal skin ODC.
  • GTP stimulated ODC activity in 4/7 tumor extracts, altering kinetic parameters (Km, Vmax) variably.
  • Gel filtration revealed multiple ODC molecular weight forms in tumors, some GTP-activatable and some not.
  • Immunolocalization showed constitutively high ODC levels in tumor cells, unlike normal skin.

Conclusions:

  • Human squamous cell carcinomas can contain functionally altered ODC.
  • These alterations include changes in heat stability, GTP regulation, and molecular forms.
  • Aberrant regulation of ODC in these tumors suggests its potential role in cancer development and progression.

Related Concept Videos